Early Clinical Trial Suggests Promise for New Pancreatic Cancer Drug Combination
As reported on STAT News, a novel combination of investigational therapies from Tango Therapeutics and Revolution Medicines is generating cautious optimism after demonstrating notable tumor responses in an early-stage clinical…